companies with glp 1 drugs Big Food Is Learning to Love Weight-Loss 20 Companies in Glucagon-Like Peptide-1
Description
83% lost at least 15%

This targets the root causes of weight gain for sustainable, long-lasting results

The challenge is to support innovation while maintaining clinical standards and patient protection
Obesity also increases the risk of cardiovascular disease, where 5 kg increases in weight in adults is associated with an 11% higher risk of death from cardiovascular disease (strokes, coronary heart disease, myocardial infarction etc)

What Does This Mean For Operators
